title: [Radiation protection effect of rhIL-12 on monkey hematopoietic system].
abstract: This study was aimed to investigate the radioprotective effects of recombinant human interleukin-12 (rhIL-12) on monkey hematopoietic system, and to provide experimental evidence for future clinical prophylaxis and treatment for patients who suffered from acute radiation syndrome. In in vitro study, the effect of rhIL-12 in different concentrations (0, 1, 5, 25, 125 and 625 ng/ml) on colony forming capacity of human or monkey bone marrow-derived mononuclear cells was examined in methylcellulose H4434 medium. In in vivo study, the acute radiation syndrome model was established in 11 Rhesus monkeys which received lethal total body irradiation by 6 Gy (60)Co γ in single time irradiation. The irradiated monkeys were randomly divided into 3 subgroups: control group (n = 4) which received subcutaneous PBS injection, rhIL-12 single-dose group (n = 3) which received subcutaneous single injection of rhIL-12 (4 µg/kg) at 2 h after irradiation, and multiple-dose group (n = 4) which received subcutaneous injection of rhIL-12 (1 µg/kg per injection) at 2 h, day 3, 6 and 9 after irradiation respectively. Peripheral blood cells were counted before and after irradiation every other day. The survival status of animals were observed daily. In vitro test results showed that different concentrations of rhIL-12 obviously promoted human and healthy monkeys' bone marrow mononuclear cells to form various hematopoietic progenitor cell colonies, especial CFU-E and CFU-GM. All animals in control group died within 22 d after lethal total body irradiation, average survival time was (20.3 ± 1.2) d. Only one monkey in multiple-dose group died due to anemia on day 17. All monkeys in single-dose group survived. Compared with control group, rhIL-12-administrated monkeys' white blood cell count, hemoglobin level, platelet and reticulocyte counts showed faster recovery from high dose radiation. It is concluded that the rhIL-12 treatment can promote the bone marrow hematopoietic stem/progenitor cell colony formation in vitro and protect lethally-irradiated monkeys. There is an obvious therapeutic effect of rhIL-12 on monkeys suffered from bone marrow failure caused by severe acute radiation exposure.
authors.affiliation: Institute of Radiation Medicine, Academy of Military Medical Sciences, Beijing, China.
authors.forename: Guo-Lin
authors.initials: GL
authors.lastname: Xiong
authors.forename: Yi
authors.initials: Y
authors.lastname: Zhao
authors.forename: Shuang
authors.initials: S
authors.lastname: Xing
authors.forename: Xing
authors.initials: X
authors.lastname: Shen
authors.forename: Xue-Cheng
authors.initials: XC
authors.lastname: Ning
authors.forename: Shi-Xiang
authors.initials: SX
authors.lastname: Lu
authors.forename: Jian
authors.initials: J
authors.lastname: Li
authors.forename: Ling-Ling
authors.initials: LL
authors.lastname: Guo
authors.forename: Rui
authors.initials: R
authors.lastname: Hao
authors.forename: Ting-Chao
authors.initials: TC
authors.lastname: Chen
authors.forename: Jin-Lai
authors.initials: JL
authors.lastname: Miao
authors.forename: Ji-Chen
authors.initials: JC
authors.lastname: He
authors.forename: Qing-Liang
authors.initials: QL
authors.lastname: Luo
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology / Q000187:drug effects / Q000528:radiation effects; D002478:Cells, Cultured; D006412:Hematopoietic Stem Cells / Q000187:drug effects* / Q000528:radiation effects; D006801:Humans; D018664:Interleukin-12 / Q000494:pharmacology*; D008253:Macaca mulatta; D011837:Radiation-Protective Agents / Q000494:pharmacology*; D011993:Recombinant Fusion Proteins / Q000494:pharmacology
chemical_list: D011837:Radiation-Protective Agents; D011993:Recombinant Fusion Proteins; D018664:Interleukin-12